This is very important news. Elizabeth Unger, of the CDC, is going to give the opening address, participate in officially unveiling the center's plaque, and will deliver a closing address. Clearly, the CDC is giving its imprimatur to this approach to the illness. Major.
Perhaps this should have its own thread:
http://www.griffith.edu.au/health/national-centre-neuroimmunology-emerging-diseases/news-and-events
The 2nd International Symposium for Chronic Fatigue Syndrome/Myalgic
Encephalomyelitis
December 2013
Gold Coast, Australia
Program
Monday, December 2nd
8:30 – 9:30am National Centre for Neuroimmunology and Emerging
Diseases Opening Ceremony
8:30am Professor Sonya Marshall-Gradisnik Co-Director, National
Centre for Neuroimmunology and Emerging Diseases Griffith University,
Gold Coast, Australia - Introduction
8:35am Professor Allan Cripps Pro Vice Chancellor Health Griffith
University, Gold Coast, Australia - Welcome address
8:45am Dr Elizabeth Unger Chief, Chronic Viral Diseases Branch Centers
for Disease Control and Prevention Atlanta, United States of America -
Opening address
9:00am Professor Allan Cripps Pro Vice Chancellor Health Griffith
University, Gold Coast, Australia
Dr Elizabeth Unger Chief, Chronic Viral Diseases Branch Centers for
Disease Control and Prevention Atlanta, United States of America -
Official plaque unveiling
9:05am Professor Sonya Marshall-Gradisnik Co-Director, National Centre
for Neuroimmunology and Emerging Diseases
Griffith University, Gold Coast, Australia - Ceremony conclusion
Session 1
Session Chair: Dr Donald Staines
10:40 – 12:45pm International Delegate Presentations
10:45am Opening address - Professor Sonya Marshall-Gradisnik
Co-Director National Centre for Neuroimmunology and Emerging Diseases
Griffith University, Gold Coast, Australia
10:50am Inaugural Alison Hunter Memorial Foundation address -
Professor V. Hugh Perry University of Southampton, Southampton, United
Kingdom
11:35am Therapeutic and physiological relevance of cortistatin as a
key molecule in the development and progression of inflammatory and
autoimmune diseases - Dr Elena Gonzalez-Rey Institute of Parasitology
and Biomedicine, Granada, Spain
11:50am Therapeutic potential of the vasoactive intestinal peptide in
autoimmunity: are we ready for its clinic application? -
Professor Mario Delgado Institute of Parasitology and Biomedicine,
Granada, Spain
12:05pm Involvement of the tryptophan metabolism in neuroinflammation
- Professor Gilles Guillemin Macquarie University, Sydney, Australia
12:20pm Contribution of neuroimaging to the differentiation of Myalgic
Encephalomyelitis/Chronic Fatigue Syndrome from anxiety and depression
- Dr Richard Kwiatek Lyell McEwin Hospital, Adelaide, Australia
12:35pm Questions and open discussion
Session 2
Session Chair: Associate Professor Brett Lidbury
1:25 – 3:00pm National Centre for Neuroimmunology and Emerging
Diseases Presentations
1:25pm Current directions: National Centre for Neuroimmunology and
Emerging Diseases - Professor Sonya Marshall-Gradisnik Co-Director
National Centre for Neuroimmunology and Emerging Diseases Griffith
University, Gold Coast, Australia
1:40pm Immune dysregulation in Chronic Fatigue Syndrome/Myalgic
Encephalomyelitis - Dr Ekua Brenu Post-doctoral Fellow National Centre
for Neuroimmunology and Emerging Diseases Griffith University, Gold
Coast, Australia
2:00pm The immunological profile of Chronic Fatigue Syndrome/ Myalgic
Encephalomyelitis subgroups - Ms Sharni Hardcastle PhD Candidate
National Centre for Neuroimmunology and Emerging Diseases Griffith
University, Gold Coast, Australia
2:25pm The application of case definitions in Chronic Fatigue
Syndrome/Myalgic Encephalomyelitis research - Ms Samantha Johnston
PhD Candidate National Centre for Neuroimmunology and Emerging
Diseases Griffith University, Gold Coast, Australia
2:40pm Questions and open discussion
Session 3
Session Chair: Professor V. Hugh Perry
3:15 – 4:30pm International Delegate Presentations
3:15pm New horizons for Myalgic Encephalomyelitis/Chronic Fatigue
Syndrome - Dr Daniel Peterson Simmaron Research Institute Sierra
Internal Medicine Nevada, United States of America
3:30pm Long term outcomes in young people with Chronic Fatigue
Syndrome: Are there any predictors for outcomes? - Dr Katherine Rowe
Murdoch Children’s Research Institute, Melbourne, Australia
3:45pm Paediatric Chronic Fatigue Syndrome/Myalgic Encephalomyelitis:
State of knowledge and future directions - Dr Sarah Knight Murdoch
Children’s Research Institute, Melbourne, Australia
3:55pm The clinical management of Chronic Fatigue Syndrome/Myalgic
Encephalomyelitis in general practice - Dr Rosamund Vallings
University of Auckland, Auckland, New Zealand
4:10pm Strategies to understand molecular pathways affected in Myalgic
Encephalomyelitis/Chronic Fatigue Syndrome and establish a diagnosis -
Professor Warren Tate University of Otago, Dunedin, New Zealand
4:20pm Questions and open discussion
4:30-5:00pm The 2nd International Symposium for International Chronic
Fatigue Syndrome/Myalgic Encephalomyelitis Closing
4:30pm Mr Ross Humphreys Chair, Steering Commitee National Centre for
Neuroimmunology and Emerging Diseases Griffith University, Gold Coast,
Australia - Introduction
4:35pm Dr Elizabeth Unger Chief, Chronic Viral Diseases Branch Centers
for Disease Control and Prevention Atlanta, United States of America -
Closing address
4:50pm Mrs Christine Hunter AM Alison Hunter Memorial Foundation,
Sydney, Australia - Closing remarks
4:55pm Dr Donald Staines Co-Director National Centre for
Neuroimmunology and Emerging Diseases Griffith University, Gold Coast,
Australia - Conclusion and future directions
5:00pm Symposium conclusion
